| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-07 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |